AD109
AD109 is composed of the selective norepinephrine reuptake inhibitor Atomoxetine and the antimuscarinic agent Aroxybutynin. It demonstrates significant oral bioactivity and effectively reduces the apnea-hypopnea index (AHI) .
Product Specifications
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog